++
For further information, see CMDT Part 20-14: Sjögren Syndrome
+++
Essentials of Diagnosis
++
Dryness of eyes and dry mouth (sicca components); they occur alone or with rheumatoid arthritis or other connective tissue disease
Rheumatoid factor and antinuclear autoantibodies common
Increased incidence of lymphoma
+++
General Considerations
++
A systemic autoimmune disorder
Clinical presentation is usually dominated by dryness of the eyes and mouth due to immune-mediated dysfunction of the lacrimal and salivary glands
Can occur in isolation ("primary" Sjögren syndrome) or in association with another rheumatic disease, most frequently rheumatoid arthritis
+++
Associated conditions
++
Rheumatoid arthritis
Systemic lupus erythematosus (SLE)
Primary biliary cirrhosis
Systemic sclerosis (scleroderma)
Polymyositis
Autoimmune (Hashimoto) thyroiditis
Polyarteritis
Interstitial pulmonary fibrosis
++
Predominantly a disease of women, with a female:male ratio of 9:1
Greatest incidence between ages 40 and 60 years
++
Eyes
Ocular burning, itching, ropy secretions
"Grain of sand in the eye" sensation
Parotid glands
Dryness of the mouth (xerostomia) leads to difficulty in swallowing dry foods (like crackers), to constant thirst for fluids, and to severe dental caries
There may be loss of taste and smell
Systemic manifestations
Dysphagia, pancreatitis
Pleuritis, obstructive airways disease and interstitial lung disease (in the absence of cigarette smoking)
Neuropsychiatric dysfunction
Small vessel vasculitis
Kidney
Renal tubular acidosis (type I, distal) occurs in 20% of patients
Chronic interstitial nephritis, which may result in impaired kidney function, may be seen
+++
Differential Diagnosis
++
Sicca complex associated with other autoimmune disease, eg, sarcoidosis, rheumatoid arthritis, SLE, systemic sclerosis
Other causes of dry mouth or eyes, eg, anticholinergics, mumps, irradiation, seasonal allergies, irritation from smoking
IgG4-related systemic disease
++
Rheumatoid factor is found in 70% of patients
Antibodies against SS-A and SS-B (also called Ro and La, respectively) are often present (Table 20–7)
When SS-A antibodies are present, extraglandular manifestations are far more common
++